Cardiol Therapeutics Inc.

NASDAQ: CRDL · Real-Time Price · USD
1.31
-0.03 (-2.24%)
At close: Aug 15, 2025, 12:14 PM

Cardiol Therapeutics Cash Flow Statement

Financials in CAD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-36.68M -28.13K -30.93M -31.64M
Depreciation & Amortization
373.11K 248.35 219.91K 220.42K
Stock-Based Compensation
14.28M 4.17M 5.01M 8.5M
Other Working Capital
-849.82K 679.62 5.89M -2.27M
Other Non-Cash Items
-2.1M -4.17M 1.89M 4.21M
Deferred Income Tax
n/a n/a -9.16M -4.92M
Change in Working Capital
-931.57K 746.80 5.75M 76.52K
Operating Cash Flow
-25.06M -25.18K -27.22M -23.55M
Capital Expenditures
-21.29K -64.31 -74.71K -12.92K
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a
Investing Cash Flow
-21.29K -64.31 -74.71K -12.92K
Debt Repayment
-41.53K -55.38K -53.93K -51.92K
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-2.47M 55.32K -0.00 9.41M
Financial Cash Flow
18.84M -55.38 -53.93K 93.44M
Net Cash Flow
-4.35M -24.54K -24.43M 69.87M
Free Cash Flow
-25.08M -25.24K -27.3M -23.56M